Feature Rotating Article - BioPharm International

ADVERTISEMENT

Feature Rotating Article

Allogeneic Versus Autologous Stem-Cell Therapy

July 1, 2012

The author discusses potential manufacturing costs & challenges of allogeneic & autologous stem-cell therapy.

Scale up of Fed-Batch Culture to Produce Plasmid DNA in Escherichia coli (Peer Reviewed)

July 1, 2012

The authors present scale-up from a 5-L fermentor to a 50-L pilot-scale using the criterion of constant power consumption per unit liquid volume.

A New Era in Cell Culture Media Development

July 1, 2012

Cell-line specific complex media supplements combine chemically defined media additives into a single supplement.

A 25-Year Retrospective on Bio-Engineering

July 1, 2012

Steven S. Kuwahara, PhD, principal consultant at GXP BioTechnology LLC, gives an update on "Engineering the Cell-System Interface."

Optimizing Expression Systems

July 1, 2012

Industry experts discuss methods for optimizing protein expression in bacterial and mammalian cell lines.

Determining Process Quality Metrics for CMOs

June 1, 2012

Implementing quality by design makes the determination of quality metrics across CMOs and sponsors essential.

25 Years of BioPharma Industry Growth

June 1, 2012

A review of key industry shifts and promises for the future.

Developing Alternatives to ELISA-Based Biomarker Assays

June 1, 2012

The authors discuss a new, rapid immunoassay for the detection of biomarkers.

25 Years of Biopharmaceutical Innovation: An Expert Roundtable

June 1, 2012

Industry experts discuss significant achievements. Plus: What's in store for the future.

ADVERTISEMENT

ADVERTISEMENT

Click here